ClinConnect ClinConnect Logo
Search / Trial NCT06878144

Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project

Launched by M.D. ANDERSON CANCER CENTER · Mar 10, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

Primary Objective:

To establish MD Anderson Mucormycosis Clinical Core for the MUCOR-ADVANCE P01 Project.

* To prospectively identify, collect, and store all isolates causing proven or probable MCM in adult high-risk cancer participants.
* To prospectively identify, collect, and store relevant host samples from high-risk participants developing proven or probable MCM, along with relevant biospecimens from three control groups.
* To comprehensively annotate clinical specimens and provide information regarding the course and outcome of all MCM cases and controls.

OUTLINE:

This is an obser...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients must be 18-100 years old and have cancer and invasive mucormycosis, invasive aspergillosis, bacterial pneumonia, or a risk for fungal infection but no evidence of such infection.
  • Patients must be willing to undergo routine diagnostic procedures (e.g., phlebotomy, bronchoscopy, biopsy) as part of their regular care.
  • Exclusion Criteria:
  • • Patients who are unwilling to undergo routine diagnostic procedures as part of their regular care.

Trial Officials

Dimitrios Kontoyiannis, MD

Principal Investigator

M.D. Anderson Cancer Center

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported